Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
I think that stigma creates problems, for both patients and clinicians.
This combination provides both immediate and long-lasting energy
Hypoglycemia : For patients with diabetes, particularly those also taking insulin or sulfonylureas, hypoglycemia (low blood sugar) is a risk
And shipping came in 2 days excellent product, felt immediate results
Privately prescribed GLP-1s may not appear on the patients medical history so if a patient presents with these symptoms, healthcare professionals should enquire about GLP-1 use